Europe investments
Print page

Our Investments

All of our European investments are listed below in greater detail.  The majority of our investments are expansion-stage life science and technology companies in the Nordic region.

NeuroNova

Registered Office:

Stockholm, SWEDEN

Listed:

Unlisted

Business Area:

Private Equity Investments

Geographic Market:

Europe

Sector:

Pharma

Investment Year:

2000

Serving On The Board:

Karl Swartling Staffan Josephson

About NeuroNova

NeuroNova AB is a leader in therapeutic neurogenesis. The company researches and develops innovative therapies for disorders of the central nervous system, exploiting discoveries about regrowth and know-how of adult neuronal stem cells in the brain and neurogenesis. The objective of the company's therapies is to treat neurodegenerative diseases, such as Parkinson's disease, ALS and Huntington's disease.

For more information visit www.neuronova.com

 

Information updated 2008-07-29 07:52:38

 
  

© Investor AB, Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden. Telephone: +46 8 614 20 00 | Investor mobile web | Cookies

This website is not intended to offer or to promote the offer or sale of Investor AB securities in the United States or to U. S. persons